Lowcountry company developing vision loss treatments
Our next guest’s company became an SC Launch member company in 2019, receiving a $25,000 academic startup grant. Three years later, they became an SC Launch portfolio company with a $200,000 investment. And all because of treatments they are developing to address vision loss. Mike Switzer interviews Michael Voevodsky, president and CEO of MitoChem Therapeutics in Charleston, SC.